Procalcitonin, C-reactive protein and APACHE II score for risk evaluation in patients with severe pneumonia
- 1 February 2002
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 8 (2) , 93-100
- https://doi.org/10.1046/j.1469-0691.2002.00349.x
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Endotoxin, Cytokines, and Procalcitonin in Febrile Patients Admitted to the Hospital: Identification of Subjects at High Risk of MortalityClinical Infectious Diseases, 2000
- Diagnostic Value of Procalcitonin Serum Levels in Neutropenic Patients with Fever: Comparison with Interleukin-8Scandinavian Journal of Infectious Diseases, 1999
- Ventilator-associated pneumonia—Understanding epidemiology and pathogenesis to guide prevention and empiric therapyClinical Microbiology & Infection, 1997
- Procalcitonin and C‐reactive protein levels in neonatal infectionsActa Paediatrica, 1997
- Procalcitonin in patients with and without immunosuppression and sepsisInfection, 1996
- C-reactive protein as an indicator of resolution of sepsis in the intensive care unitIntensive Care Medicine, 1995
- High serum procalcitonin concentrations in patients with sepsis and infectionPublished by Elsevier ,1993
- The spectrum of patients strongly influences the usefulness of diagnostic tests for pneumoniaScandinavian Journal of Primary Health Care, 1993
- CDC definitions for nosocomial infections, 1988American Journal of Infection Control, 1988
- APACHE IICritical Care Medicine, 1985